Vitamin D deficiency is caused due to limited exposure to sunlight light and reduced intake of vitamin D through the diet sources. Vitamin D deficiency may lead to severe health conditions including, heart diseases, diabetes, high blood pressure, infections and immune system disorders among others. The lack of vitamin D shows symptoms such as pain, fatigue and depression, and muscle weakness. Therefore, to treat vitamin D deficiency supplements of vitamin D are available in the market.
MARKET DYNAMICS
The vitamin D deficiency treatment market growth is estimated to grow due to the increasing prevalence of Vitamin D deficiencies, growing demand for OTC products, and rising demand from the consumers segment of older age group. The outbreak of COVID-19 pandemic has offer vital growth opportunities to increase sales of vitamin D supplements as people across the world were prohibited to move out of their houses, which have restricted exposure to the natural source of vitamin D.
MARKET SCOPE
The "Vitamin D Deficiency Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of vitamin D deficiency treatment market with detailed market segmentation by product type, type, route of administration, and distribution channel. The vitamin D deficiency treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in vitamin D deficiency treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The vitamin D deficiency treatment market is segmented on the basis of product type, type, route of administration, and distribution channel. Based on product type, the market is classified as prescribed supplements, and OTC supplements. Based on type, the market is segmented as vitamin D2, and vitamin D3. Based on route of administration the market is divided as oral, injection, and sublingual. And on the basis of distribution channel, the market is segmented as Hospital and retail pharmacies, online distribution, and hyper and super markets.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the vitamin D deficiency treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The vitamin D deficiency treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vitamin D deficiency treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vitamin D deficiency treatment market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the vitamin D deficiency treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The vitamin D deficiency treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vitamin D deficiency treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vitamin D deficiency treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the vitamin D deficiency treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vitamin D deficiency treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for vitamin D deficiency treatment market in the global market. Below mentioned is the list of few companies engaged in the vitamin D deficiency treatment market.
The report also includes the profiles of key players in vitamin D deficiency treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Novartis AG
- Bayer AG
- GlaxoSmithKline plc
- Mankind Pharma
- Reckitt Benckiser Group plc
- BASF SE
- Glanbia PLC
- Teva Pharmaceutical Industries Ltd
- Sanofi
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vitamin D Deficiency Treatment Market - By Product Type
1.3.2 Vitamin D Deficiency Treatment Market - By Type
1.3.3 Vitamin D Deficiency Treatment Market - By Route of Administration
1.3.4 Vitamin D Deficiency Treatment Market - By Distribution Channel
1.3.5 Vitamin D Deficiency Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VITAMIN D DEFICIENCY TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VITAMIN D DEFICIENCY TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VITAMIN D DEFICIENCY TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. VITAMIN D DEFICIENCY TREATMENT - GLOBAL MARKET OVERVIEW
6.2. VITAMIN D DEFICIENCY TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. VITAMIN D DEFICIENCY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRESCRIBED SUPPLEMENTS
7.3.1. Overview
7.3.2. Prescribed Supplements Market Forecast and Analysis
7.4. OTC SUPPLEMENTS
7.4.1. Overview
7.4.2. OTC Supplements Market Forecast and Analysis
8. VITAMIN D DEFICIENCY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. VITAMIN D2
8.3.1. Overview
8.3.2. Vitamin D2 Market Forecast and Analysis
8.4. VITAMIN D3
8.4.1. Overview
8.4.2. Vitamin D3 Market Forecast and Analysis
9. VITAMIN D DEFICIENCY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTION
9.4.1. Overview
9.4.2. Injection Market Forecast and Analysis
9.5. SUBLINGUAL
9.5.1. Overview
9.5.2. Sublingual Market Forecast and Analysis
10. VITAMIN D DEFICIENCY TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL AND RETAIL PHARMACIES
10.3.1. Overview
10.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
10.4. ONLINE DISTRIBUTION
10.4.1. Overview
10.4.2. Online Distribution Market Forecast and Analysis
10.5. HYPER AND SUPER MARKETS
10.5.1. Overview
10.5.2. Hyper and Super Markets Market Forecast and Analysis
11. VITAMIN D DEFICIENCY TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Vitamin D Deficiency Treatment Market Overview
11.1.2 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis
11.1.3 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Product Type
11.1.4 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Type
11.1.5 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Vitamin D Deficiency Treatment Market
11.1.7.1.1 United States Vitamin D Deficiency Treatment Market by Product Type
11.1.7.1.2 United States Vitamin D Deficiency Treatment Market by Type
11.1.7.1.3 United States Vitamin D Deficiency Treatment Market by Route of Administration
11.1.7.1.4 United States Vitamin D Deficiency Treatment Market by Distribution Channel
11.1.7.2 Canada Vitamin D Deficiency Treatment Market
11.1.7.2.1 Canada Vitamin D Deficiency Treatment Market by Product Type
11.1.7.2.2 Canada Vitamin D Deficiency Treatment Market by Type
11.1.7.2.3 Canada Vitamin D Deficiency Treatment Market by Route of Administration
11.1.7.2.4 Canada Vitamin D Deficiency Treatment Market by Distribution Channel
11.1.7.3 Mexico Vitamin D Deficiency Treatment Market
11.1.7.3.1 Mexico Vitamin D Deficiency Treatment Market by Product Type
11.1.7.3.2 Mexico Vitamin D Deficiency Treatment Market by Type
11.1.7.3.3 Mexico Vitamin D Deficiency Treatment Market by Route of Administration
11.1.7.3.4 Mexico Vitamin D Deficiency Treatment Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Vitamin D Deficiency Treatment Market Overview
11.2.2 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis
11.2.3 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Product Type
11.2.4 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Type
11.2.5 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Vitamin D Deficiency Treatment Market
11.2.7.1.1 Germany Vitamin D Deficiency Treatment Market by Product Type
11.2.7.1.2 Germany Vitamin D Deficiency Treatment Market by Type
11.2.7.1.3 Germany Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.1.4 Germany Vitamin D Deficiency Treatment Market by Distribution Channel
11.2.7.2 France Vitamin D Deficiency Treatment Market
11.2.7.2.1 France Vitamin D Deficiency Treatment Market by Product Type
11.2.7.2.2 France Vitamin D Deficiency Treatment Market by Type
11.2.7.2.3 France Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.2.4 France Vitamin D Deficiency Treatment Market by Distribution Channel
11.2.7.3 Italy Vitamin D Deficiency Treatment Market
11.2.7.3.1 Italy Vitamin D Deficiency Treatment Market by Product Type
11.2.7.3.2 Italy Vitamin D Deficiency Treatment Market by Type
11.2.7.3.3 Italy Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.3.4 Italy Vitamin D Deficiency Treatment Market by Distribution Channel
11.2.7.4 Spain Vitamin D Deficiency Treatment Market
11.2.7.4.1 Spain Vitamin D Deficiency Treatment Market by Product Type
11.2.7.4.2 Spain Vitamin D Deficiency Treatment Market by Type
11.2.7.4.3 Spain Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.4.4 Spain Vitamin D Deficiency Treatment Market by Distribution Channel
11.2.7.5 United Kingdom Vitamin D Deficiency Treatment Market
11.2.7.5.1 United Kingdom Vitamin D Deficiency Treatment Market by Product Type
11.2.7.5.2 United Kingdom Vitamin D Deficiency Treatment Market by Type
11.2.7.5.3 United Kingdom Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.5.4 United Kingdom Vitamin D Deficiency Treatment Market by Distribution Channel
11.2.7.6 Rest of Europe Vitamin D Deficiency Treatment Market
11.2.7.6.1 Rest of Europe Vitamin D Deficiency Treatment Market by Product Type
11.2.7.6.2 Rest of Europe Vitamin D Deficiency Treatment Market by Type
11.2.7.6.3 Rest of Europe Vitamin D Deficiency Treatment Market by Route of Administration
11.2.7.6.4 Rest of Europe Vitamin D Deficiency Treatment Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Vitamin D Deficiency Treatment Market Overview
11.3.2 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Vitamin D Deficiency Treatment Market
11.3.7.1.1 Australia Vitamin D Deficiency Treatment Market by Product Type
11.3.7.1.2 Australia Vitamin D Deficiency Treatment Market by Type
11.3.7.1.3 Australia Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.1.4 Australia Vitamin D Deficiency Treatment Market by Distribution Channel
11.3.7.2 China Vitamin D Deficiency Treatment Market
11.3.7.2.1 China Vitamin D Deficiency Treatment Market by Product Type
11.3.7.2.2 China Vitamin D Deficiency Treatment Market by Type
11.3.7.2.3 China Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.2.4 China Vitamin D Deficiency Treatment Market by Distribution Channel
11.3.7.3 India Vitamin D Deficiency Treatment Market
11.3.7.3.1 India Vitamin D Deficiency Treatment Market by Product Type
11.3.7.3.2 India Vitamin D Deficiency Treatment Market by Type
11.3.7.3.3 India Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.3.4 India Vitamin D Deficiency Treatment Market by Distribution Channel
11.3.7.4 Japan Vitamin D Deficiency Treatment Market
11.3.7.4.1 Japan Vitamin D Deficiency Treatment Market by Product Type
11.3.7.4.2 Japan Vitamin D Deficiency Treatment Market by Type
11.3.7.4.3 Japan Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.4.4 Japan Vitamin D Deficiency Treatment Market by Distribution Channel
11.3.7.5 South Korea Vitamin D Deficiency Treatment Market
11.3.7.5.1 South Korea Vitamin D Deficiency Treatment Market by Product Type
11.3.7.5.2 South Korea Vitamin D Deficiency Treatment Market by Type
11.3.7.5.3 South Korea Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.5.4 South Korea Vitamin D Deficiency Treatment Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Vitamin D Deficiency Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Vitamin D Deficiency Treatment Market by Product Type
11.3.7.6.2 Rest of Asia-Pacific Vitamin D Deficiency Treatment Market by Type
11.3.7.6.3 Rest of Asia-Pacific Vitamin D Deficiency Treatment Market by Route of Administration
11.3.7.6.4 Rest of Asia-Pacific Vitamin D Deficiency Treatment Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Vitamin D Deficiency Treatment Market Overview
11.4.2 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Vitamin D Deficiency Treatment Market
11.4.7.1.1 South Africa Vitamin D Deficiency Treatment Market by Product Type
11.4.7.1.2 South Africa Vitamin D Deficiency Treatment Market by Type
11.4.7.1.3 South Africa Vitamin D Deficiency Treatment Market by Route of Administration
11.4.7.1.4 South Africa Vitamin D Deficiency Treatment Market by Distribution Channel
11.4.7.2 Saudi Arabia Vitamin D Deficiency Treatment Market
11.4.7.2.1 Saudi Arabia Vitamin D Deficiency Treatment Market by Product Type
11.4.7.2.2 Saudi Arabia Vitamin D Deficiency Treatment Market by Type
11.4.7.2.3 Saudi Arabia Vitamin D Deficiency Treatment Market by Route of Administration
11.4.7.2.4 Saudi Arabia Vitamin D Deficiency Treatment Market by Distribution Channel
11.4.7.3 U.A.E Vitamin D Deficiency Treatment Market
11.4.7.3.1 U.A.E Vitamin D Deficiency Treatment Market by Product Type
11.4.7.3.2 U.A.E Vitamin D Deficiency Treatment Market by Type
11.4.7.3.3 U.A.E Vitamin D Deficiency Treatment Market by Route of Administration
11.4.7.3.4 U.A.E Vitamin D Deficiency Treatment Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Vitamin D Deficiency Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Vitamin D Deficiency Treatment Market by Product Type
11.4.7.4.2 Rest of Middle East and Africa Vitamin D Deficiency Treatment Market by Type
11.4.7.4.3 Rest of Middle East and Africa Vitamin D Deficiency Treatment Market by Route of Administration
11.4.7.4.4 Rest of Middle East and Africa Vitamin D Deficiency Treatment Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Vitamin D Deficiency Treatment Market Overview
11.5.2 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis
11.5.3 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Type
11.5.5 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Vitamin D Deficiency Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Vitamin D Deficiency Treatment Market
11.5.7.1.1 Brazil Vitamin D Deficiency Treatment Market by Product Type
11.5.7.1.2 Brazil Vitamin D Deficiency Treatment Market by Type
11.5.7.1.3 Brazil Vitamin D Deficiency Treatment Market by Route of Administration
11.5.7.1.4 Brazil Vitamin D Deficiency Treatment Market by Distribution Channel
11.5.7.2 Argentina Vitamin D Deficiency Treatment Market
11.5.7.2.1 Argentina Vitamin D Deficiency Treatment Market by Product Type
11.5.7.2.2 Argentina Vitamin D Deficiency Treatment Market by Type
11.5.7.2.3 Argentina Vitamin D Deficiency Treatment Market by Route of Administration
11.5.7.2.4 Argentina Vitamin D Deficiency Treatment Market by Distribution Channel
11.5.7.3 Rest of South and Central America Vitamin D Deficiency Treatment Market
11.5.7.3.1 Rest of South and Central America Vitamin D Deficiency Treatment Market by Product Type
11.5.7.3.2 Rest of South and Central America Vitamin D Deficiency Treatment Market by Type
11.5.7.3.3 Rest of South and Central America Vitamin D Deficiency Treatment Market by Route of Administration
11.5.7.3.4 Rest of South and Central America Vitamin D Deficiency Treatment Market by Distribution Channel
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VITAMIN D DEFICIENCY TREATMENT MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. VITAMIN D DEFICIENCY TREATMENT MARKET, KEY COMPANY PROFILES
14.1. PFIZER INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. NOVARTIS AG
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BAYER AG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. GLAXOSMITHKLINE PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MANKIND PHARMA
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. RECKITT BENCKISER GROUP PLC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BASF SE
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. GLANBIA PLC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. SANOFI
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Pfizer Inc.
2. Novartis AG
3. Bayer AG
4. GlaxoSmithKline plc
5. Mankind Pharma
6. Reckitt Benckiser Group plc
7. BASF SE
8. Glanbia PLC
9. Teva Pharmaceutical Industries Ltd
10. Sanofi
11. Biogen SA
12. Sun Pharmaceuticals Limited
13. Cipla Inc.
14. Dr Reddy's laboratories Ltd
15. DSM
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Vitamin D Deficiency Treatment Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)